IBERE PHARMACEUTICALS

Ibere Pharmaceuticals (ticker: IBER) is a blank check company that filed its S-1 registration statement with the Securities and Exchange Commission on February 9, 2021, entering the market during one of the most active periods for SPAC formation on record. The vehicle was structured to identify and pursue an acquisition target in the pharmaceutical and life sciences sector. The 2021 filing placed IBER among a large cohort of healthcare-focused SPACs that came to market that year as investor appetite for the blank check structure reached historically elevated levels. Sign up at SpacDesk for the full sponsor profile, warrant details, and current deal status on IBER.